The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.
about
Antibiotic prophylaxis for the prevention of methicillin-resistant Staphylococcus aureus (MRSA) related complications in surgical patientsAntimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonizationReal-time in vivo bioluminescent imaging for evaluating the efficacy of antibiotics in a rat Staphylococcus aureus endocarditis modelReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsDalbavancin in the treatment of complicated skin and soft-tissue infections: a reviewAntimicrobial resistance: the example of Staphylococcus aureusOptimizing antibiotic therapy in the intensive care unit setting.Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit.Mechanisms of vancomycin resistance in Staphylococcus aureusStructure of sortase, the transpeptidase that anchors proteins to the cell wall of Staphylococcus aureusCrystal structure of a phenol-coupling P450 monooxygenase involved in teicoplanin biosynthesisRates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient populationIncreasing resistance to vancomycin and other glycopeptides in Staphylococcus aureusEvolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKRComparative study of the susceptibilities of major epidemic clones of methicillin-resistant Staphylococcus aureus to oxacillin and to the new broad-spectrum cephalosporin ceftobiprole.GenHtr: a tool for comparative assessment of genetic heterogeneity in microbial genomes generated by massive short-read sequencing.Response of complicated methicillin-resistant Staphylococcus aureus endocarditis to the addition of trovafloxacin.Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.Methicillin-resistant Staphylococcus aureus: a 5-year review of surveillance data in a tertiary care hospital in Saudi Arabia.Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates.Dialysis-associated peritonitis in children.Antimicrobial resistance in gram-positive bacteria: the myth of the MIC. Minimum inhibitory concentration.Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-associated infections.Necrosis of Staphylococcus aureus by the Electrospun Fe- and Ag-Doped TiO2 Nanofibers.Staphylococcus aureus bacteremia in patients undergoing hemodialysis.Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005Purification and characterization of sortase, the transpeptidase that cleaves surface proteins of Staphylococcus aureus at the LPXTG motif.Observation of "seesaw effect" with vancomycin, teicoplanin, daptomycin and ceftaroline in 150 unique MRSA strains.Staphylococcus heterogeneously resistant to vancomycin in China and antimicrobial activities of imipenem and vancomycin in combination against itHeterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital.Molecular epidemiology of Staphylococcus epidermidis in a neonatal intensive care unit over a three-year period.Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital.Vancomycin-intermediate Staphylococcus aureus in Korea.Clonal groups of penicillin-nonsusceptible Streptococcus pneumoniae in Baltimore, Maryland: a population-based, molecular epidemiologic study.First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand.Three-year assessment of methicillin-resistant Staphylococcus aureus clones in Latin America from 1996 to 1998.Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresisNationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals.Molecular detection of antimicrobial resistanceReversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates
P2860
Q24200384-F377F9B1-4050-477E-B8B8-7630C42B088AQ24247771-F12D3A7B-B68F-42F5-954D-B555A664D379Q24558684-376E441C-193F-4D11-AFF0-E83BD6085A5CQ24646677-037A6349-B0C6-4E88-A7F0-CEFBA52A0F08Q24647429-CA57F740-0A6D-4D88-B448-B5CA7DAD7A28Q24676363-C9B5AFB6-0CEF-424F-BF82-EA8E906E4A07Q24796204-0F5F852B-237C-48ED-BB4D-7975472174ECQ24813204-55A929BB-6556-44A7-B909-5E19587A9B67Q26829312-148B28DA-7CC6-405B-8BE9-4F6C7C531E1DQ27631984-94CFBA3A-CC34-4919-AE97-2A0F11F5CB78Q27667347-00F028F4-6898-4714-B5E7-0D4A76EF6A3BQ28182298-471336BC-DD8C-47FA-98FF-C6B7E024C7A3Q28362193-13982E87-23AC-464C-96B5-AB13412FF9A2Q28477900-C2C8FBBF-581B-4E70-949C-C9FDE310B051Q30369604-D009B33A-93B1-4EA2-9CFA-CE76AD24F3E8Q30990230-2B6E80B7-FFE2-4B25-9663-CFBFDA5E716CQ31372845-18B35A0F-2A6A-430C-9651-AA5D9944B323Q31704853-FF3842C9-9114-40B2-A16A-C1FC0623378CQ33290348-DD9BDC09-E0C6-4CB7-BD33-F13874DBA6A4Q33594576-2BA790F2-3361-4EB4-BA06-C4ED2996B6E5Q33606206-9E04F854-43C2-492A-9972-6EEB13D939F8Q33717162-F962BF6E-CC53-4D5D-9128-2B213606D041Q33769625-0315538E-0AB2-4235-8639-F57726A0DF0CQ33776656-C50143D2-73E4-429D-9A0A-45F854FEC469Q33877475-DD047094-9870-4C72-B084-0E7C88CF1AFAQ33877838-DA8CF785-4C04-49CB-B05F-9262A03993A9Q33878138-319D5871-3E7F-48BD-9D85-CB45A29F310EQ33939095-5EE8ECAE-A100-4CC7-BBF2-B3386D0BA812Q33951678-EB66D7A2-7806-425E-81E8-444635AC302AQ33965630-8378D5A6-CF19-4DCF-9161-11C34046FA13Q33966785-CB6655C1-34B2-4006-90CC-C1EC58A620F3Q33968859-951C59F1-4278-4096-942A-34DF8423C4B8Q33970102-DB65CA8F-4DC1-4102-A7E7-A3E72EDF2974Q33970496-5E1BD68C-B9A3-4D06-BD8C-DB6F286DDAE0Q33971217-5DCB6B1D-7117-403C-AAE2-DC61702B404AQ33972582-E5174D0E-74E2-47A2-84F8-11779C694628Q33973574-611610A1-A3AA-4617-9C69-371FEAE9154BQ33974326-0C94C53B-E15B-4950-9DBB-7D4654847460Q33975793-E2BA6FA3-E95B-48D1-8679-189EB22CFE33Q33978642-E3892712-973E-4CC3-94DC-14E2BD3FC1B2
P2860
The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
The development of vancomycin ...... aphylococcus aureus infection.
@en
The development of vancomycin ...... aphylococcus aureus infection.
@nl
type
label
The development of vancomycin ...... aphylococcus aureus infection.
@en
The development of vancomycin ...... aphylococcus aureus infection.
@nl
prefLabel
The development of vancomycin ...... aphylococcus aureus infection.
@en
The development of vancomycin ...... aphylococcus aureus infection.
@nl
P2093
P1476
The development of vancomycin ...... aphylococcus aureus infection.
@en
P2093
P304
P356
10.1056/NEJM199902183400704
P407
P577
1999-02-01T00:00:00Z